Klarissa D Jackson

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Drug metabolism reviews

Biomolecules

Pharmaceutics

University of North Carolina at Chapel Hill

Vanderbilt University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina at Chapel Hill Jul 01 2019

United States

Assistant Professor :: Division of Pharmacotherapy and Experimental Therapeutics

Lipscomb University College of Pharmacy and Health Sciences Jul 25 2013 - Jun 30 2019

United States

Assistant Professor :: Pharmaceutical Sciences

Education History

Vanderbilt University School of Medicine Aug 18 2006 - May 11 2011

United States

PHD :: Pharmacology

Publications

Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jonghwa Lee, Jessica L Beers, Raeanne M Geffert, Klarissa D Jackson
A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. Biomolecules 14 (1) (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Jonghwa Lee, Jessica L Beers, Raeanne M Geffert, Klarissa D Jackson
A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. Biomolecules 14 (1) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Bethany D Latham, Raeanne M Geffert, Klarissa D Jackson
Kinase Inhibitors FDA Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Bethany D Latham, Raeanne M Geffert, Klarissa D Jackson
Kinase Inhibitors FDA Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Bethany D Latham, Raeanne M Geffert, Klarissa D Jackson
Kinase Inhibitors FDA-Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities. Drug metabolism and disposition: the biological fate of chemicals (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals (2024)
Jonghwa Lee, Jessica L Beers, Raeanne M Geffert, Klarissa D Jackson
A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. Biomolecules 14 (1) (2024)
Bethany D Latham, Raeanne M Geffert, Klarissa D Jackson
Kinase Inhibitors FDA Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Jessica L Beers, Zhu Zhou, Klarissa D Jackson
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals (2024)
Bethany D Latham, Raeanne M Geffert, Klarissa D Jackson
Kinase Inhibitors FDA-Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities. Drug metabolism and disposition: the biological fate of chemicals (2024)
Jonghwa Lee, Jessica L Beers, Raeanne M Geffert, Klarissa D Jackson
A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. Biomolecules 14 (1) (2024)
Lixuan Qian, Jessica L Beers, Klarissa D Jackson, Zhu Zhou
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. Pharmaceutics 16 (4) (2024)
Klarissa D Jackson, Brahim Achour, Jonghwa Lee, Raeanne M Geffert, Jessica L Beers, Bethany D Latham
Novel approaches to characterize individual drug metabolism and advance precision medicine. Drug metabolism and disposition: the biological fate of chemicals (2023)
Jessica L Beers, Aurora K Authement, Nina Isoherranen, Klarissa D Jackson
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. ACS medicinal chemistry letters 14 (5) (2023)
Jessica L Beers, Aurora K Authement, Nina Isoherranen, Klarissa D Jackson
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. ACS medicinal chemistry letters 14 (5) (2023)
Jonghwa Lee, John K Fallon, Philip C Smith, Klarissa D Jackson
Formation of CYP3A-specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β-hydroxycholesterol/cholesterol ratio. Clinical and translational science (2022)
Elizabeth A Burnham, Arsany A Abouda, Jennifer E Bissada, Dasean T Nardone-White, Jessica L Beers, Jonghwa Lee, Matthew J Vergne, Klarissa D Jackson
Interindividual Variability in Cytochrome P450 3A and 1A Activity Influences Sunitinib Metabolism and Bioactivation. Chemical research in toxicology 35 (5) (2022)
S Cyrus Khojasteh, Upendra A Argikar, Sungjoon Cho, Rachel D Crouch, Carley J S Heck, Kevin M Johnson, Amit S Kalgutkar, Lloyd King, Hlaing Holly Maw, Herana Kamal Seneviratne, Shuai Wang, Cong Wei, Donglu Zhang, Klarissa D Jackson
Biotransformation novel advances - 2021 year in review. Drug metabolism reviews 54 (3) (2022)
Boris Reidel, Sabri Abdelwahab, Joe Alexander Wrennall, Phillip W Clapp, Jessica L Beers, Klarissa D Jackson, Robert Tarran, Mehmet Kesimer
Vaping additives cannabinoid oil and vitamin E acetate adhere to and damage the human airway epithelium. Journal of applied toxicology : JAT (2022)
Bethany D Latham, D Spencer Oskin, Rachel D Crouch, Matthew J Vergne, Klarissa D Jackson
Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib. Chemical research in toxicology 35 (9) (2022)
Klarissa D Jackson, Upendra A Argikar, Sungjoon Cho, Rachel D Crouch, James P Driscoll, Carley J S Heck, Lloyd King, Hlaing Holly Maw, Grover P Miller, Herana Kamal Seneviratne, Shuai Wang, Cong Wei, Donglu Zhang, S Cyrus Khojasteh
Bioactivation and reactivity research advances - 2021 year in review. Drug metabolism reviews 54 (3) (2022)
S Cyrus Khojasteh, Upendra A Argikar, James P Driscoll, Carley J S Heck, Lloyd King, Klarissa D Jackson, Wenying Jian, Amit S Kalgutkar, Grover P Miller, Valerie M Kramlinger, Ivonne M C M Rietjens, Aaron M Teitelbaum, Kai Wang, Cong Wei
Novel advances in biotransformation and bioactivation research - 2020 year in review. Drug metabolism reviews 53 (3) (2021)
Dasean T Nardone-White, Jennifer E Bissada, Arsany A Abouda, Klarissa D Jackson
Detoxication versus Bioactivation Pathways of Lapatinib In Vitro: UGT1A1 Catalyzes the Hepatic Glucuronidation of Debenzylated Lapatinib. Drug metabolism and disposition: the biological fate of chemicals 49 (3) (2020)
S Cyrus Khojasteh, James P Driscoll, Klarissa D Jackson, Grover P Miller, Kaushik Mitra, Ivonne M C M Rietjens, Donglu Zhang
Novel advances in biotransformation and bioactivation research-2019 year in review. Drug metabolism reviews 52 (3) (2020)
Jennifer E Bissada, Vivian Truong, Arsany A Abouda, Kahari J Wines, Rachel D Crouch, Klarissa D Jackson
Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation. Drug metabolism and disposition: the biological fate of chemicals 47 (11) (2019)
Jessica L Murray, Susan L Mercer, Klarissa D Jackson
Impact of cytochrome P450 variation on meperidine N-demethylation to the neurotoxic metabolite normeperidine. Xenobiotica; the fate of foreign compounds in biological systems 50 (2) (2019)
Gracia M Amaya, Rebecca Durandis, David S Bourgeois, James A Perkins, Arsany A Abouda, Kahari J Wines, Mohamed Mohamud, Samuel A Starks, R Nathan Daniels, Klarissa D Jackson
Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib. Chemical research in toxicology 31 (7) (2018)

Klarissa D Jackson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Klarissa D Jackson